Kinshuk Kocher, Co-Founder, Caredose
Some of the most valuable lessons in healthcare are learned far away from boardrooms and investment committees. They come from understanding how care is actually delivered, how patients navigate treatment in their daily lives, and why even well-designed technologies fail when they do not fit into real clinical workflows.
Those lessons have shaped every stage of Kinshuk Kocher’s career.
Today, Kocher serves as Director of Investment Operations and Special Projects at Cedars-Sinai Technology Ventures (CSTV) in Los Angeles, where he helps identify and support emerging healthcare technologies. He has evaluated more than 500 health-tech startups through the Cedars-Sinai Accelerator+ and has contributed to over US$20 million in institutional investments across more than ten companies. Yet the perspective he brings to evaluating innovation was formed years earlier while building a healthcare company in India.
Before becoming an investor, Kocher was a founder working on one of healthcare’s most persistent challenges: helping patients take their medicines consistently.
Building Caredose Around a Real Healthcare Challenge
In 2017, Kocher co-founded Caredose, a medication management company focused on improving medication adherence for patients living with chronic conditions.
Medication adherence remains a significant challenge worldwide. Patients managing long-term conditions often need to take multiple medicines at different times each day, making treatment difficult to follow consistently. Missed doses, incorrect timing and medication confusion can reduce treatment effectiveness and increase the burden on both patients and healthcare providers.
Rather than approaching the problem as simply a reminder or compliance issue, Caredose focused on simplifying the medication experience itself. The platform organised medicines into clearly labelled, dose-wise pouches that helped patients follow their prescribed schedules while supporting pharmacies and healthcare providers with a more structured dispensing process.
Building that solution required far more than developing technology.
Over the next four years, the team worked closely with pharmacies, hospitals and healthcare providers to understand how medication management functioned in everyday clinical practice. Caredose managed more than one million medicine doses across India, improved medication adherence from below 50 per cent to over 80 per cent among provider partners, and collaborated with organisations including Apollo Pharmacy, Max Hospitals, the World Health Organization (WHO), USAID and the Gates Foundation.
For Kocher, however, the biggest outcome was not simply building a successful company. It was gaining a firsthand understanding of how healthcare innovation succeeds or fails once it reaches patients and providers.
“You learn very quickly that solving a healthcare problem is about much more than building good technology,” says Kocher. “You have to understand how patients, pharmacists, caregivers and providers interact with the system every day. Those realities shape whether an innovation is actually adopted.”
Looking at Innovation Through an Operator’s Lens
Following Caredose’s successful exit, Kocher took on a senior digital health role at GSK before joining Cedars-Sinai Technology Ventures.
The move represented a shift from building healthcare solutions to evaluating them, but many of the questions guiding his decisions remained unchanged.
Working across both the Indian and American healthcare ecosystems has also given Kocher a broader perspective on how innovation reaches patients.
While the healthcare challenges may be similar, the path to adoption can be very different. Clinical workflows, procurement processes, reimbursement models and regulatory environments all influence how quickly new technologies become part of routine care.
Understanding those realities has become an important part of how he assesses emerging companies.
Rather than focusing only on technical sophistication, Kocher looks for founders who demonstrate a clear understanding of the clinical environments in which their products will operate.
“The most promising healthcare companies are usually built by teams that have spent time understanding the people they are serving,” he says. “Technology is important, but long-term adoption depends on whether a solution fits naturally into existing clinical workflows and genuinely improves patient or provider experiences.”
What Hundreds of Startup Evaluations Reinforced
Evaluating more than 500 healthcare startups has allowed Kocher to observe recurring patterns across the industry.
Many companies begin with impressive technologies, but the strongest businesses are often those that combine innovation with a deep understanding of healthcare delivery. They recognise that adoption depends not only on clinical evidence or technical capability, but also on whether solutions can be integrated into existing workflows without creating unnecessary complexity.
These are lessons Kocher first encountered while building Caredose.
Experiencing the operational realities of healthcare firsthand gave him an appreciation for the challenges that cannot be identified from market reports alone. It also reinforced the importance of designing products around real-world behaviour rather than idealised assumptions.
That founder experience continues to influence how he evaluates entrepreneurs today.
Building Better Healthcare Through Experience
Kocher’s career has taken him from building a medication management company in India to supporting health-tech innovation within one of the United States’ leading academic health systems. While the scale and scope of his work have evolved, the underlying philosophy has remained remarkably consistent.
For him, meaningful healthcare innovation begins with understanding the realities of care delivery before attempting to transform them.
The experience of building Caredose continues to shape how he views new technologies, evaluates founders and identifies opportunities capable of delivering lasting impact.
“Healthcare innovation is ultimately about solving meaningful problems for patients and providers,” says Kocher. “The technology matters, but understanding how care is delivered is what turns a promising idea into something that can create lasting value.”
About Kinshuk Kocher
Kinshuk Kocher is Director of Investment Operations and Special Projects at Cedars-Sinai Technology Ventures in Los Angeles. He previously co-founded Caredose, a medication management company focused on improving adherence for patients with chronic conditions. He holds an MBA from the University of Oxford.
